VCYT
Veracyte, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website veracyte.com
- Employees(FY) 787
- ISIN US92337F1075
Performance
+0.07%
1W
+17.82%
1M
+50.44%
3M
+108.14%
6M
+56.23%
YTD
+67.83%
1Y
Profile
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Technical Analysis of VCYT 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-05 16:05
- 2024-12-05 08:51
- 2024-12-05 03:05
- 2024-11-26 19:00
- 2024-11-18 06:51
- 2024-11-15 07:34
- 2024-11-14 16:45
- 2024-11-14 13:04
High Growth Tech Stocks To Watch In November 2024(Simply Wall St.)
- 2024-11-14 09:07
- 2024-11-09 08:36
- 2024-11-08 06:12
Veracyte Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-11-07 11:00
- 2024-11-07 10:52
- 2024-11-07 10:01
- 2024-11-06 18:10
- 2024-11-06 17:05
Veracyte: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-06 16:05
Veracyte Announces Third Quarter 2024 Financial Results(Business Wire)
- 2024-11-06 03:05
Veracyte Announces Third Quarter 2024 Financial Results(Businesswire)
- 2024-11-04 18:43
What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings(Yahoo Finance)
- 2024-10-30 17:00
Veracyte to Participate in Upcoming Investor Conferences(Business Wire)
- 2024-10-30 07:14
- 2024-10-30 05:00
Veracyte to Participate in Upcoming Investor Conferences(Businesswire)
- 2024-10-16 18:43
- 2024-10-16 10:06
High Growth Tech Stocks To Watch In October 2024(Simply Wall St.)
- 2024-10-16 08:22
UBS Initiates Veracyte at Buy With $43 Price Target(MT Newswires)
- 2024-10-16 07:09
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?(Simply Wall St.)
- 2024-10-16 06:43
- 2024-10-11 09:40
- 2024-10-10 08:38
- 2024-10-09 17:07
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.